StockNod.com
Stock Trading Software - Chart Pattern Screener with Stock Alerts and Scans
Home
Chart Pattern Stock Alerts
Stock Scans
Stock Alerts Demo Video
Free Stock Newsletter
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Press releases about
Pfizer Announces Expiration of Subsequent Offering Period and Completion of Tender Offer for Shares of Icagen, Inc.
September 20, 2011
from
Business Wire News Releases
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
September 13, 2011
from
Business Wire News Releases
Pfizer Announces Successful Completion of Initial Cash Tender Offer for Outstanding Shares of Icagen, Inc. and Commencement of Subsequent Offering Period
September 06, 2011
from
Business Wire News Releases
Pfizer Extends Tender Offer To Acquire Icagen, Inc.
September 02, 2011
from
Business Wire News Releases
Merlin Nexus and New Leaf Venture Partners Comment on Extension of Tender Offer Deadline in Conjunction with Pfizer's Proposed $56 Million Acquisition of Icagen
September 01, 2011
from
PR Newswire
Pfizer Extends Tender Offer to Acquire Icagen, Inc.
September 01, 2011
from
Business Wire News Releases
Icagen Reaffirms Recommendation to Shareholders to Tender Shares
August 29, 2011
from
GlobeNewswire News Releases
Merlin Nexus and New Leaf Venture Partners Continue to Contest Proposed $56 Million Acquisition of Icagen by Pfizer
August 25, 2011
True Acquisition Cost to Pfizer Estimated at Approximately $22 Million, Yet Icagen's Pain Programs Are Estimated to Be Worth $100-$165 Million
Read More
from
PR Newswire
Icagen Reiterates Its Recommendation That Stockholders Accept Pfizer's Offer of $6 Per Share
August 16, 2011
from
GlobeNewswire News Releases
Icagen Stockholders Send Second Letter to Icagen Board to Contest Proposed Price of Acquisition by Pfizer
August 11, 2011
from
Business Wire News Releases
Icagen Reports Second Quarter 2011 Financial Results and Operational Highlights
August 10, 2011
from
GlobeNewswire News Releases
Icagen Stockholders Contest Proposed Acquisition Price by Pfizer in Letter to Board
July 28, 2011
from
Business Wire News Releases
Bull & Lifshitz, LLP Announces Investigation of Icagen, Inc.
July 21, 2011
from
Business Wire News Releases
Ryan & Maniskas, LLP Announces Investigation of Icagen, Inc.
July 21, 2011
from
Business Wire News Releases
Murray Frank LLP Investigates Icagen, Inc.
July 20, 2011
from
Business Wire News Releases
The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Icagen, Inc.
July 20, 2011
from
Business Wire News Releases
Faruqi & Faruqi, LLP Announces Investigation of ICAgen, Inc.
July 20, 2011
from
Business Wire News Releases
The Law Firm of Levi & Korsinsky, LLP Announces Investigation of Icagen, Inc.
July 20, 2011
from
Business Wire News Releases
Finkelstein Thompson LLP Announces Investigation of Icagen, Inc.
July 20, 2011
from
Business Wire News Releases
Rigrodsky & Long, P.A. Announces Investigation of Icagen, Inc.
July 20, 2011
from
Business Wire News Releases
Law Office of Brodsky & Smith, LLC Announces Investigation of Icagen, Inc.
July 20, 2011
from
Business Wire News Releases
Law Firm Brower Piven Announces Investigation of Icagen, Inc.
July 20, 2011
from
Business Wire News Releases
Tripp Levy PLLC Announces Investigation of Icagen
July 20, 2011
from
Business Wire News Releases
Pfizer to Acquire Icagen
July 20, 2011
from
GlobeNewswire News Releases
Pfizer To Acquire Icagen
July 20, 2011
from
Business Wire News Releases
Equity Research on Icagen, Inc. and Celgene Corporation - Biopharmaceuticals Have the Cure
June 28, 2011
from
Marketwired News Releases
ICGN, YRCW and MDCE are the Stocks to Watch for June 28h from OTCPicks.com
June 28, 2011
from
EmailWire.Com Press Releases
Icagen Issues Statement in Response to Pfizer SEC Filing
June 24, 2011
from
GlobeNewswire News Releases
Icagen and Pfizer Initiate Nav 1.7 Phase I Multiple Ascending Dose Study
June 20, 2011
from
GlobeNewswire News Releases
Icagen Reports First Quarter 2011 Financial Results And Operational Highlights
May 04, 2011
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here